Delivery Order SPE2DB25D3008-SPE2DB25FRDGH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,730.56 to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5ML) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order, with no set-aside designation, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vaxelis vaccine vials (0.5 mL). This firm fixed-price delivery order, valued at $2,591.38, is not set-aside and represents a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $18,464.42 to AmerisourceBergen Drug Corp for the supply of Vaxelis vaccine in 0.5mL vials. This firm fixed-price delivery order, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a $3,836.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for Vaxelis vaccine syringes in 0.5ML quantities. The order, which is non-set-aside and competitively awarded, has an ultimate completion date of April 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $24,239.08 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) on September 14, 2025, with completion targeted for September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract is being...
- The Defense Logistics Agency awarded a $3,499.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5 mL) with an ultimate completion date of September 9, 2025. This non-set-aside contract was awarded competitively on September 8, 2025, with performance at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5mL) valued at $12,956.80 under a firm fixed-price contract with an ultimate completion date of July 28, 2025. This non-set-aside delivery order, issued on July 25, 2025, represents a discrete transaction under AmerisourceBergen's broader pharmaceutical supply relationship with DLA, with performance to occur at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,791.57 to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5 mL) on August 20, 2025, with completion scheduled for August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 6, 2025, by the Defense Logistics Agency (DLA) for the supply of Vaxelis vaccine vials (0.5 mL) with a contract value of $6,173.93 and an ultimate completion date of August 7, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine syringes (0.5mL) valued at $6,394.80 under a firm fixed-price contract. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, will perform this work...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRDGHDelivery Order
The Defense Logistics Agency awarded a $7,774.14 delivery order to AmerisourceBergen Drug Corp for Vaxelis vaccine vials (0.5 mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's federal contracting demonstrates consistent capability to supply a broad spectrum of pharmaceutical products and medical supplies, including vaccines, medications, and specialized medical commodities across multiple therapeutic domains. Through the parent SPE2DX indefinite delivery contract, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning this Vaxelis vaccine order as part of the company's ongoing role in supporting military and federal health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 9/15/25 |